Categories
Articles

Fed Cuts 1/4 Point

Bear (BSC) for $2 a share and now a quarter point rate cut…..tomorrow will be interseting..

http://online.wsj.com/article/SB120571194513840285.html??mod=djemalertNEWS

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

How Did We Get Here?

In reviewing Whitney Tilson’s 75 page presentation of the current crisis, one page jumped out at me. They say a picture says a thousand words?

If you want to know what happened to housing and mortgages, this slide tells it all.


In reviewing Whitney Tilson’s 75 page presentation of the current crisis, one page jumped out at me. They say a picture says a thousand words?

You can download the presentation here or email me and I will send it to you.
Disclosure (“none” means no position):Tilson fan,

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

Bear Sterns Bailout (Video)

Watching Kudlow & Company the other night and saw this..

Don Luskin and Larry have a great discussion on Bear Sterns (BSC) and the current liquidity situation.

Disclosure (“none” means no position):None

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

"Fast Money" for Monday


Monday’s Picks

None

Friday’s Results
Joe Terranova recommends Calpine Corp. (CPN) $17.54 Close $17.22 LOSS

Guy Adami prefers Home Depot (HD) $26.48 Close $25.75 LOSS

Karen Finerman likes Goldman Sachs (GS) $165.44 Close $156.86 LOSS

Pete Najarian thinks Genentech (DNA) $81.43 is a buy. Close $78.83 LOSS

2008 Records:
Brian Schaeffer= 0-1
Carter Worth= 0-1
Jon Najarian= 4-1
Jeff Macke= 17-13
Tim Seymore= 9-6
Guy Adami= 18-19
Pete Najarian= 17-16
Karen Finerman= 16-20-1
Joe Terrenova= 0-1
2007 Results (Since 6/21):
Guy Adami= 58-46 = 56%
Jeff Macke= 60-40 = 60%
Pete Najarian= 49-41 = 54%

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

Sardar Biglari Discloses Additional Steak n’ Shake Holding

Through his control of “The Lion Fund” Western Sizzlin’ (WEST) CEO Biglari disclosed that on 3/12 he acquired interest in 2.4 million shares of Steak n’ Shake (SNS)

From the SEC filing:

1. Mr. Biglari, as Chief Executive Officer of Biglari Capital Corp., the General Partner of The Lion Fund, L.P. (“Lion Fund”), may be deemed to beneficially own the securities of the Issuer beneficially owned by the Lion Fund. Mr. Biglari disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
2. Mr. Biglari, as a member of a Section 13(d) group with respect to the securities of the Issuer with Philip L. Cooley, may be deemed to beneficially own an additional 15,300 shares of the Issuer beneficially owned by Mr. Cooley. Mr. Biglari disclaims beneficial ownership of such shares.
3. Mr. Biglari, as Chief Executive Officer of Western Acquisitions L.P. (“Western Acquisitions”), may be deemed to beneficially own the securities of the Issuer beneficially owned by Western Acquisitions. Mr. Biglari disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

So who is Biglari and what is Western Sizzlin’?

George, over at Fat Pitch Financials has done the most extensive work on the Western Sizzlin (WEST) to date. I suggest you read his reasoning for buying it here and here.

Regarding Bilgari and Steak n’ Shake, George addresses that in his most recent post on the subject.

Biglari has done some very interesting things at Western and his action are worth a closer look. I am going to look closer at this in the future.

Disclosure (“none” means no position):None

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

The Week’s Insider Buys

This list get larger every week…

Cabela S Inc (CAB)-$7,654,000
Aquila Inc New (ILA)-$4,053,000
XTL Biopharmaceuticals Ltd (XTLB)-$3,881,000
Lions Gate Entertainment Corp (LGF)-$3,448,000
Enterprise Products Partners LP (EPD)- $2,623,000
Stereotaxis Inc (STXS)-$2,053,000
General Electric Co (GE )-$2,042,000
Ntelos Holdings Corp (NTLS)-$1,748,000
Builders Firstsource Inc (BLDR)-$1,706,000
Citadel Broadcasting Corp (CDL)-$1,690,000
New York Community Bancorp Inc (NYB)-$1,590,000
WebMD Health Corp (WBMD)- $1,524,000
La Jolla Pharmaceutical Co (LJPC)-$1,168,000
M & F Worldwide Corp (MFW)-$1,157,000
PSB Holdings Inc New (PSBH)- $1,019,000
Psychiatric Solutions Inc New (PSYS)-$1,019,000
Weis Markets Inc (WMK )- $1,005,000
Silverleaf Resorts Inc (SVLF)-$1,004,000

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

The Week’s Best At VIN

Here are the week’s top stories at Value Investing News

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

Icahn Files 13D on Enzon Pharma

Carl Icahn filed a 13D regarding his stake in Enzon Pharmaceuticals (ENZN) today.

Icahn now may be deemed to beneficially own, in the aggregate, 3,072,103 Shares, representing approximately 6.93% of Enzon’s outstanding Shares (based upon the 44,322,923 Shares

Also,

“The Reporting Persons have entered into a number of derivative agreements, commonly known as Total Return Swaps, with counterparties, which agreements provide that the profit to the Reporting Persons shall be based upon the increase in value of the Shares and the loss to the Reporting Persons shall be based upon the decrease in the value of the Shares, during the period from inception of the applicable agreement to its termination. The agreements provide that they settle in cash. In addition to the Shares which they beneficially own as shown in Item 5 above, the Reporting Persons currently have long economic exposure to an aggregate of 3,552,897 Shares through such agreements.”

Enzon:
Enzon Pharmaceuticals, Inc. (Enzon) is a biopharmaceutical company focused on the development, manufacturing and commercialization of medicines for patients with cancer and other life-threatening conditions. The Company has a portfolio of four marketed products: Oncaspar, DepoCyt, Abelcet and Adagen. Enzon’s drug development programs utilize several approaches, including its PEGylation technology platform. The PEGylation technology was used to develop two of Enzon’s products, Oncaspar and Adagen, and has created a royalty revenue stream from licensing partnerships for other products developed using the technology. The Company is also engaged in contract manufacturing for several pharmaceutical companies.

Why the interest?
“The Reporting Persons acquired their positions in the Shares in the belief that they were undervalued. The Reporting Persons have had conversations with members of the Issuer’s management during which the Reporting Persons expressed their concern with the current Share price. In addition, during these conversations, the Reporting Persons indicated that management should conduct a comprehensive review of strategic transactions that could enhance shareholder value, including a spinoff or other monetization of certain assets, such as royalty streams and products with limited market potential; or a sale of the entire company. No agreement, arrangement or understanding was reached between the Reporting Persons and management. The Reporting Persons intend to seek to have further conversations with management.”

Disclosure (“none” means no position):None

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

Friday’s Links

Sovereign Wealth,Cramer on Eliot, Southwest (LUV), Culture

– This is a great oped. Why are we so afraid of these funds when we already have them?

– Watch this, does it make me terrible that I just started laughing……hysterically?

– In case you were not nervous enough to fly..

– This makes sense. With the deterioration of the family, culture takes on more prevalence.

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

Insider Trading in Bear Stearns Puts?

Time to call a duck a duck SEC…

Disclosure (“none” means no position):

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

Get Rid of Kneale and Gasparino

Nothing to do with investing… but am I the only one who is sick of seeing these two? Every segment they are in dissolves into this stuff..

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

Buffett Talks About SIV’s

Here is an interview with Buffett in which he talks about the current situation.

Disclosure (“none” means no position):None

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

Bruce Berkowitz on Sears Holdings

Here is a Bloomberg interview with Fairholme’s Bruce Berkowitz in which he talks about Sears Holdings

Disclosure (“none” means no position):Long SHLD

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

$3.25 Gas Helping Harley Davidson?

As gas approaches $4 a gallon, are consumer going to switch to two wheels to save money? It would seem early results are ..yes.

The questions was posed to an Illinois Harley Dealer recently.

Shad Zimbro, co-owner of Black Diamond Harley Davidson in Marion, Illinois says,”It really is the truth because they do save a lot of money in gas by going to a motorcycle.” He says his sales have doubled since last year.

Motorcycles tend to average about 50 miles a gallon and Harley makes models that get 70. Zimbro says he commutes 40 miles a day to work on his Harley and saves about $100 a week by doing so.

It does make perfect sense but obviously we need more data to see if it is just a regional trend or a larger on. The significance of his increase though, is impressive and that does lead me to believe it may be more than a local event.

In January Harley did issue 2008 guidance above the consensus estimates so perhaps they are seeing something?

We’ll have to wait until late spring to get more info but I am thinking that this may actually be something larger..

Disclosure (“none” means no position):Long HOG

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

Friday’s Upgrades and Downgrades


Upgrades
UnionBanCal (UB)- Punk, Ziegel & Co Mkt Perform » Buy
JA Solar (JASO)- Needham & Co Buy » Strong Buy
Unisource Energy (UNS)- Soleil Hold » Buy
Leap Wireless (LEAP)- Wachovia Underperform » Mkt Perform
Millennium Pharm (MLNM)- Piper Jaffray Neutral » Buy
Humana (HUM)- UBS Sell » Neutral
JA Solar (JASO)- Lehman Brothers Equal-weight » Overweight
NIDEC (NJ)- JP Morgan Neutral » Overweight
GSI Commerce (GSIC)- Jefferies & Co Hold » Buy
Wimm-Bill-Dann Foods (WBD)- Credit Suisse Neutral » Outperform
Monsanto (MON)- Banc of America Sec Neutral » Buy
AstraZeneca (AZN)- UBS Sell » Neutral

Downgrades
Hot Topic (HOTT)- BB&T Capital Mkts Buy » Hold
Raven Industries (RAVN)- Dougherty & Company Buy » Neutral
Sigma Designs (SIGM)- BWS Financial Strong Buy » Hold
Orbcomm (ORBC)- Oppenheimer Outperform » Perform
Glu Mobile (GLUU)- Deutsche Securities Hold » Sell
PNC Bank (PNC)- Keefe Bruyette Outperform » Mkt Perform
Fed Investors (FII)- UBS Buy » Neutral

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books